Medicinal Benefits of Marine Invertebrates. Sources for Discovering Natural Drug Candidates

Advances in Food and Nutrition Research

Volumn 65, Issue , 2012, Pages 153-169

  De Zoysa, Mahanama ^a  

^a Chungnam National University   (South Korea)

Author keywords

Drugs; Marine invertebrates; Medicinal foods; Mollusks; Natural products; Spongers

Indexed keywords

EID: 84857205755     PISSN: 10434526     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-416003-3.00009-3     Document Type: Chapter

References (106)

1. Alam N., Hong J., Lee C.O., Choi J.S., Im K.S., Jung J.H. Additional cytotoxic diacetylenes from the stony coral Montipora sp. Chem. Pharm. Bull. (Tokoyo) 2002, 50:661-662.
2. Amade P., Charroin C., Baby C., Vacelet J. Antimicrobial activities of marine sponges from the Mediterranean Sea. Mar. Biol. 1987, 94:271-275.
3. Andersson L., Lidgren G., Bohlin L., Magni L., Ogren S., Afzelius L. Studies of Swedish marine organisms I: Screening of biological activity. Acta Pharm. Suec. 1983, 20:401-414.
4. Aroma New Zealand Ltd Company Profile and Product Specification 2007, http://www.aromanz.com.
5. Bagnis R., Berglund F., Elias P.S., Van Esch G.J., Halstead B.W., Kojima K. Problems of toxicants in marine food products. Bull. World Health Organ. 1970, 42:69-88.
6. Belarbi E.H., Gomez A.C., Chisti Y., Camacho F.G., Grima E.M. Producing drugs from marine sponges. Biotechnol. Adv. 2003, 21:585-598.
7. Benkendorff K. Molluscan biological and chemical diversity: Secondary metabolites and medicinal resources produced by marine mollusks. Biol. Rev. 2010, 85:757-775.
8. Bergmann W., Feeney R.J. Contributions to the study of marine products XXXII. The nucleosides of sponges. J. Org. Chem. 1951, 16:981-987.
9. Bingham J.P., Mitsunaga E., Bergeron Z.L. Drugs from slugs-past, present and future perspectives of ώ-conotoxin research. Chem. Biol. Interact. 2010, 183:1-18.
10. Blunt J.W., Copp B.R., Munro M.H.G., Northcote P.T., Prinsep M.R. Marine natural products. Nat. Prod. Rep. 2004, 21:1-49.
11. Blunt J.W., Copp B.R., Hu W.P., Munro M.H.G., Northcote P.T., Prinsep M.R. Marine natural products. Nat. Prod. Rep. 2007, 24:31-86.
12. Borresen T. Seafood for improved health and wellbeing. Food Technol. 2009, 63:88.
13. Bouchet P. The magnitude of marine biodiversity. The Exploration of Marine Biodiversity, Scientific and Technological Challenges 2006, 33-64. Foundation BBVA, France. http://www.fbbva.es, C.M. Duarte (Ed.).
14. Bugni T.S., Harper M.K., McCulloch M.W.B., Reppart J., Ireland C.M. Fractionated marine invertebrate extract libraries for drug discovery. Molecules 2008, 13:1372-1383.
15. Caddy J.F. Marine Invertebrate Fisheries: Their Assessment and Management 1989, John Wiley and Sons, New York, p. 752.
16. Capon R.J., Vuong D., Lacey E., Gill J.H. Echinobetaine A: Isolation, structure elucidation, synthesis, and preliminary SAR studies on a new nematocidal betaine from a southern Australian marine sponge, Echinodictyum sp. J. Nat. Prod. 2005, 68:179-182.
17. Cesaretti M., Luppi E., Maccari M., Volpi N. Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes philippinarum. Evidence for the presence of a high content of antithrombin III-binding site. Glycobiology 2004, 14:1275-1284.
18. Cutignano A., Bifulco G., Bruno I., Casapullo A., Gomez-Paloma L., Riccio R. Dragmacidin F: A new antiviral bromoindole alkaloid from the Mediterranean sponge Halicortex spp. Tetrahedron 2000, 56:3743-3748.
19. Davidson S.K., Haygood M.G. Identification of sibling species of the Bryozoan Bugula neritina that produce different anticancer bryostatins and harbor distinct strains of the bacterial symbiont "Candidatus Endobugula sertula" Biol. Bull. 1999, 196:273-280.
20. Davidson S.K., Allen S.W., Lim G.E., Anderson C.M., Haygood M.G. Evidence for the biosynthesis of bryostatins by the bacterial symbiont "Candidatus Endobugula sertula" of the Bryozoan Bugula neritina. Appl. Environ. Microbiol. 2001, 67:4531-4537.
21. De Zoysa M., Whang I., Lee Y., Lee S., Lee J.S., Lee J. Defensin from disk abalone Haliotis discus discus: Molecular cloning, sequence characterization and immune response against bacterial infection. Fish Shellfish Immunol. 2010, 28:261-266.
22. Erwin P.M., Lopez-Legentil S., Schuhmann P.W. The pharmaceutical value of marine biodiversity for anti-cancer drug discovery. Ecol. Econ. 2010, 70:445-451.
23. Fakhr I., Hamdy N., Radwan M., El-Batran S., El Shabrawy O. Studies on the anti-inflammatory and analgesic effects of extracts from marine sponges. Nat. Prod. Sci. 2006, 12:74-78.
24. Fieseler L., Horn M., Wagner M., Hentschel U. Discovery of the novel candidate Phylum "Poribacteria" in marine sponges. Appl. Environ. Microbiol. 2004, 70:3724-3732.
25. Folmer F., Jaspars M., Dicato M., Diederich M. Marine natural products as targeted modulators of the transcription factor NF-κB. Biochem. Pharmacol. 2008, 75:603-617.
26. Fujita T., Fukase M., Miyamoto H., Matasumoto T., Ohue T. Increase of bone mineral density by calcium supplement with oyster shell electrolysate. Bone Miner. 1990, 11:85-91.
27. Gonzales M., Gueguen Y., Desserre G., de Lorgeril J., Romestand B., Bachere E. Molecular characterization of two isoforms of defensin from hemocytes of the oyster Crassostrea gigas. Dev. Comp. Immunol. 2007, 31:332-339.
28. Gopal R., Vijayakumaran M., Venkatesan R., Kathiroli S. Marine organisms in Indian medicine and their future prospects. Nat. Prod. Rad. 2008, 7:139-145.
29. Grammaticos P.C., Diamantis A. Useful known and unknown views of the father of modern medicine Hippocrates and his teacher Democritus. Hell. J. Nucl. Med. 2008, 11:2-4.
30. Hale K.J., Manaviazar S. New approaches to the total synthesis of bryostatin antitumor macrolides. Chem. Asian J. 2010, 5:704-754.
31. Han T.S., Teichert R.W., Olivera B.M., Bulaj G. Conus venoms-a rich source of peptide-based therapeutics. Curr. Pharm. Des. 2008, 14:2462-2479.
32. Harish Prashanth K.V., Tharanathan R.N. Chitin/chitosan: Modifications and their unlimited application potential. Trends Food Sci. Technol. 2007, 18:117-131.
33. Harris M., Bruhn C., Schor D., Kapsak W.R., Blakistone B. Communicating the net benefits of seafood consumption. Food Technol. 2009, 63:38-44.
34. Hentschel U., Hopke J., Horn M., Friedrich A.B., Wagner M., Hacker J., Moore B.S. Molecular evidence for a uniform microbial community in sponges from different oceans. Appl. Environ. Microbiol. 2002, 68:4431-4440.
35. Hill R.T., Fenical W. Pharmaceuticals from marine natural products: Surge or ebb?. Curr. Opin. Biotechnol. 2010, 21:777-779.
36. Hovingh P., Linker A. An unusual heparin sulfate isolated from lobsters (Homarus americanus). J. Biol. Chem. 1982, 16:9840-9844.
37. Hsieh Y.H.P., Rudloe J. Potential of utilizing jellyfish as food in Western countries. Trends Food Sci. Technol. 1994, 5:225-229.
38. Hsieh Y.H.P., Leong F.M., Barnes K.W. Inorganic constituent in fresh and processed cannonball jellyfish (Stomolophus meleagris). J. Agric. Food Chem. 1996, 44:3117-3119.
39. Hsieh Y.H.P., Leong F.M., Rudloe J. Jellyfish as food. Hydrobiologia 2001, 451:11-17.
40. Hu G.P., Yuan J., Sun L., She Z.G., Wu J.H., Lan X.J., Zhu X., Lin Y.C., Chen S.P. Statistical research on marine natural products based on data obtained between 1985 and 2008. Mar. Drugs 2011, 9:514-525.
41. Hubert F., Noel T., Roch P. A member of the arthropod defensin family from edible Mediterranean mussels (Mytilus galloprovincialis). Eur. J. Biochem. 1996, 240:302-306.
42. Jha R.K., Zi-rong X. Biomedical compounds from marine organisms. Mar. Drugs 2004, 2:123-146.
43. Jordan R.E., Marcum J.A. Anticoagulant active heparin from clam (Mercenaria mercenaria). Arch. Biochem. Biophys. 1986, 248:690-695.
44. Jung W.K., Rajapakse N., Kim S.K. Antioxidative activity of a low molecular weight peptide derived from the sauce of fermented blue mussel, Mytilus edulis. Eur. Food Res. Technol. 2005, 220:535-539.
45. Kamiya H., Sakai R., Jimbo M. Bioactive molecules from sea hares. Prog. Mol. Subcell. Biol. 2006, 43:215-239.
46. Kelman D., Kashman Y., Rosenberg E., Kushmaro A., Loya Y. Antimicrobial activity of red sea corals. Mar. Biol. 2006, 149:357-363.
47. Kim H.L., Kang S.G., Kim I.C., Kim S.J., Kim D.W., Ma S.J., Gao T., Li H., Kim M.U., Lee T.H. In vitro Anti-hypertensive, antioxidant and anticoagulant activities of extracts from Haliotis discus hannai. J. Korean Soc. Food Sci. Nutr. 2006, 35:835-840.
48. Kim E.K., Kim Y.S., Lee S.J., Jeon Y.J., Lee J.D., Son T.I., Ahn C.B., Kim Y.T., Moon S.H., Jeon B.T. Anticancer effect of lipids partially purified from Pacific oyster, Crassostrea gigas on PC3 cells. Food Sci. Biotechnol. 2010, 19:213-217.
49. Kimura Y., Ohminami H., Okuda H. Effects of extract of oyster on lipid metabolism in rats. J. Ethnopharmacol. 1998, 59:117-123.
50. Kuzirian A.M., Epstein H.T., Gagliardi C.J., Nelson T.J., Sakakibara M., Taylor C., Scioletti A.B., Alkon D.L. Bryostatin enhancement of memory in Hermissenda. Biol. Bull. 2006, 210:201-214.
51. Larsen R., Eilertsen K.E., Elvevoll E.O. Health benefits of marine foods and ingredients. Biotechnol. Adv. 2011, 29:508-518.
52. Layer R.T., McIntosh J.M. Conotoxins: Therapeutic potential and application. Mar. Drugs 2006, 4:119-142.
53. Lee Y.K., Lee J.H., Lee H.K. Microbial symbiosis in marine sponges. J. Microbiol. 2001, 39:254-264.
54. Lee C.G., Kwon H.K., Ryu J.H., Kang S.J., Im C.R., Kim J.I., Im S.H. Abalone visceral extract inhibit tumor growth and metastasis by modulating Cox-2 levels and CD8+ T cell activity. BMC Complement. Altern. Med. 2010, 10:60.
55. Lev E. Traditional healing with animals (Zootherapy): Medieval to present day Levantine practice. J. Ethnopharmacol. 2003, 86:107-118.
56. Linington R.G., Robertson M., Gauthier A., Finlay B.B., MacMillan J.B., Molinski T.F., van Soest R., Andersen R.J. Caminosides B-D, antimicrobial glycolipids isolated from the marine sponge Caminus sphaeroconia. J. Nat. Prod. 2006, 69:173-177.
57. Lippert H., Brinkmeyer R., Iken K. Antimicrobial activity in sub-Arctic marine invertebrates. Polar Biol. 2003, 26:591-600.
58. Luppi E., Cesaretti M., Volpi N. Purification and characterization of heparin from the Italian clam Callista chione. Biomacromolecules 2005, 6:1672-1678.
59. Martinez M.J.A., Olmo L.M.B.D., Benito P.B. Natural marine antiviral products. Bioact. Nat. Prod. 2008, 35:101-134.
60. Mayer A.M.S., Rodriguez A.D., Berlinck R.G.S., Hamann M.T. Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, antiinflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Biochim. Biophys. Acta 2009, 5:283-308.
61. Melo V.M.M., Fonseca A.M., Vasconcelos I.M., Carvalho A.F. Purification of a novel antibacterial and haemagglutinating protein from the purple gland of the sea hare, Aplysia dactylomela Rang, 1828. Toxicon 1998, 38:1415-1427.
62. Meylan A. Nutritional characteristics of the sponges in the diet of the hawksbill turtle Eretmochelys imbricata. New Perspectives in Sponge Biology 1990, 472-477. Smithsonian, Institution Press, Washington, DC. K. Rutzler (Ed.).
63. Miyashita K., Hosokawa M. Beneficial health effects of seaweed carotenoid, fucoxanthin. Marine Nutraceuticals and Functional Foods 2008, 297-320. CRC Press, Boca Raton, USA. C. Barrow, F. Shahidi (Eds.).
64. Montoya-Cadavid E., Romero P.F., Winston J.E. Check list of the marine Bryozoa of the Colombian Caribben. Biota Colombiana 2007, 8:159-184.
65. Munro M.H.G., Blunt J.W., Barns G., Battershill C.N., Lake R.J., Perry N.B. Biological activity in New Zealand marine organisms. Pure Appl. Chem. 1989, 61:529-534.
66. Narkowicz C.K., Blackman A.J., Lacey E., Gill J.H., Heiland K. Convolutindole A and convolutamine H, new nematocidal brominated alkaloids from the marine bryozoan Amathia convoluta. J. Nat. Prod. 2002, 65:938-941.
67. Newman D., Cragg G.M. Marine natural products and related compounds in clinical and advanced preclinical trials. J. Nat. Prod. 2004, 67:1216-1238.
68. Newman D., Cragg G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007, 70:461-477.
69. Nie S.Q., Li T.L., Jiang A.H., Li G.Q. A comparative study on anti-ulcer action of unprepared and calcined oyster shell. Zhongguo Zhong Yao Za Zhi 1994, 19:405-407.
70. Olivera B.M., McIntosh J.M., Lourdes J.C., Luque F.A., Gray W.R. Purification and sequence of a presynaptic peptide toxin from Conus geographus venom. Biochemistry 1984, 23:5087-5090.
71. Palmer C.V., Modi C.K., Mydlarz L.D. Coral fluorescent proteins as antioxidants. PLoS One 2009, 4:e7298.
72. Pan H.M., Huang Y.T., Chang C.I., Ho C.T., Pan B.S. Apoptotic-inducing epidioxysterols identified in hard clam (Meretrix lusoria). Food Chem. 2007, 102:788-795.
73. Pawlik J.R. Marine invertebrate chemical defenses. Chem. Rev. 1993, 93:1911-1922.
74. Pechenic J.A. Biology of Invertebrates 2000, McGraw Hill, New York. 4th edn.
75. Pejler G., Danielsson A., Bjork I., Lindahl U. Structure and antithrombin-binding properties of heparin isolated from the clams Anomalocardia brasiliana and Tivela mactroides. J. Biol. Chem. 1987, 262:11413-11421.
76. Phillipson D.W., Rinehart K.L. Antifungal peroxide-containing acids from two Caribbean sponges. J. Am. Chem. Soc. 1983, 105:7735-7736.
77. Ponder W.F., Lindberg D.R. Phylogeny and Evolution of Mollusca 2008, University of California Press, Berkley, p. 469.
78. Qian Z.J., Jung W.K., Byun H.G., Kim S.K. Protective effect of an antioxidative peptide purified from gastrointestinal digests of oyster, Crassostrea gigas against free radical induced DNA damage. Bioresour. Technol. 2008, 99:3365-3371.
79. Rajaganapathi J., Kathiresan K., Singh T.P. Purification of Anti-HIV Protein from Purple fluid of the sea hare Bursatella leachii de Blainville. Mar. Biotechnol. 2002, 4:447-453.
80. Riguera R. Isolating bioactive compounds from marine organisms. J. Mar. Biotechnol. 1997, 5:187-193.
81. Rinehart K.L., Shaw P.D., Shield L.S., Gloer J.B., Harbour G.C., Koker M.E.S., Samain D., Schwartz R.E., Tymiak A.A., Weller D.L., Carter G.T., Munro M.H.G., et al. Marine natural products as sources of antiviral, antimicrobial, and antineoplastic agents. Pure Appl. Chem. 1981, 59:795-817.
82. Sachindra N.M., Bhaskar N., Mahendrakar N.S. Carotenoids in crabs from marine and fresh waters of India. Food Sci. Technol. 2005, 38:221-225.
83. Sammarco P.W., Coll J.C. Chemical adaptations in the Octocorallia: Evolutionary considerations. Mar. Ecol. Prog. Ser. 1992, 88:93-104.
84. Schnapp D., Schnapp D., Kemp G.D., Smith V.J. Purification and characterization of a proline-rich antibacterial peptide, with sequence similarity to bactenecin 7, from the haemocytes of the shore crab, Carcinus maenas. Eur. J. Biochem. 1996, 240:532-539.
85. Schwartsmann G., da Rocha A.B., Berlinck R.G., Jimeno J. Marine organisms as a source of new anticancer agents. Lancet Oncol. 2001, 2:221-225.
86. Seo J.K., Crawford J.M., Stone K.L., Noga E.J. Purification of a novel arthropod defenisn from the American oyster, Crassostrea virginica. Biochem. Biophys. Res. Commun. 2005, 338:1998-2004.
87. Sipkema D., Franssen M.C.R., Osinga R., Tramper J., Wijffels R.H. Marine sponges as pharmacy. Mar. Biotechnol. 2005, 7:142-162.
88. Skov M.J., Beck J.C., de Kater A.W., Shopp G.M. Nonclinical safety of ziconotide: An intrathecal analgesic of a new pharmaceutical class. Int. J. Toxicol. 2007, 26:411-421.
89. Slattery M., McClintock J.B., Heine J.N. Chemical defense in Antarctic soft corals: Evidence for antifouling compounds. J. Exp. Mar. Biol. Ecol. 1995, 190:61-71.
90. Smith V.J., Fernandes J.M.O., Kemp G.D., Hauston C. Crustins: Enigmatic WAP domain-containing antibacterial proteins from crustaceans. Dev. Comp. Immunol. 2008, 32:758-772.
91. Smith V.J., Desbois A.P., Dyrynda E.A. Conventional and unconventional antimicrobials from fish, marine invertebrates and micro-algae. Mar. Drugs 2010, 8:1213-1262.
92. Sperstad S.V., Haug T., Blencke H.M., Styrvol O.B., Li C., Stensvag K. Antimicrobial peptides from marine invertebrates: Challengers and perspectives in marine antimicrobial peptide discovery. Biotechnol. Adv. 2011, 29:519-530.
93. Tadesse M., Gulliksen B., Strøm M.B., Styrvold O.B., Haug T. Screening for antibacterial and antifungal activities in marine benthic invertebrates from northern Norway. J. Invertebr. Pathol. 2008, 99:286-293.
94. Thomas T.R.A., Kavlekar D.P., LokaBharathi P.A. Marine drugs from sponge-microbe association. Mar. Drugs 2010, 8:1417-1468.
95. Thorpe J.P., Sole-Cava A.M., Watts P.C. Exploited marine invertebrates: Genetics and fisheries. Hydrobiologia 2000, 420:165-184.
96. Tou J.C., Jaczynski J., Chen Y.C. Krill for human consumption: Nutritional value and potential health benefits. Nutr. Rev. 2007, 65:63-77.
97. Twede V.D., Miljanich G., Olivera B.M., Bulaj G. Neuroprotective and cardioprotective conopeptides: An emerging class of drug leads. Curr. Opin. Drug Discov. Devel. 2009, 12:231-239.
98. Uchida H., Sasaki T., Uchida N.A., Takasuka N., Endo Y., Kamiya H. Oncostatic and immunomodulatory effects of a glycoprotein fraction from water extract of abalone, Haliotis discus hannai. Cancer Immunol. Immunother. 1987, 24:207-212.
99. Volk C.A., Kock M. Viscoline: New 3-alkyl pyridinium from the Arctic sponge Haliclona viscose. Org. Biomol. Chem. 2004, 2:1827-1830.
100. Voultsiadou E. Therapeutic properties and uses of marine invertebrates in the ancient Greek world and early Byzantum. J. Ethnopharmacol. 2010, 130:237-247.
101. Voultsiadou E., Vafidis D. Marine invertebrates diversity in Aristotle's zoology. Contrib. Zool. 2007, 76:103-120.
102. Weinheimer A.J., Spraggins R.L. The occurrence of two new prostaglandin derivatives (15-epi-PGA2 and its acetate, methyl ester) in the gorgonian Plexaura homomalla, Chemistry of coelenterates. Tetrahedron Lett. 1969, 5185-5188.
103. Williams P.G. Panning for chemical gold: Marine bacteria as a source of new therapeutics. Trends Biotechnol. 2008, 27:45-52.
104. Yamazaki M. Antitumor and antimicrobial glycoproteins from sea hare. Comp. Biochem. Physiol. C 1993, 105:141-146.
105. Yesilada E. Past and future contributions to traditional medicine in the health care system of the Middle-East. J. Ethnopharmacol. 2005, 100:135-137.
106. Yeung H.C. Handbook of Chinese Herbal Formulas 1983, Institute of Chinese Medicine, Rosemead, LA, USA.